Combined Antiangiogenic Therapy and Immunotherapy Is Effective for Pancreatic Cancer With Mismatch Repair Proficiency but High Tumor Mutation Burden: A Case Report

Immunotherapy has been recommended as a second-line treatment only for high microsatellite instability or DNA mismatch repair deficiency advanced pancreatic cancer in National Comprehensive Cancer Network guidelines. Here, we report a case with a good response to immunotherapy in pancreatic cancer w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mengni, Yang, Shengli, Fan, Li, Wu, Lu, Chen, Renwang, Chang, Jian, Hu, Jianli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830947/
https://www.ncbi.nlm.nih.gov/pubmed/31609933
http://dx.doi.org/10.1097/MPA.0000000000001398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830947/
https://www.ncbi.nlm.nih.gov/pubmed/31609933
http://dx.doi.org/10.1097/MPA.0000000000001398

Ejemplares similares